Xiaojun Liu

534 total citations
30 papers, 365 citations indexed

About

Xiaojun Liu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xiaojun Liu has authored 30 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Xiaojun Liu's work include DNA Repair Mechanisms (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and PARP inhibition in cancer therapy (3 papers). Xiaojun Liu is often cited by papers focused on DNA Repair Mechanisms (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and PARP inhibition in cancer therapy (3 papers). Xiaojun Liu collaborates with scholars based in China, United States and Thailand. Xiaojun Liu's co-authors include Qingqing Lu, Geng Tian, Jidong Lang, Bo Wang, Pingping Bing, Jialiang Yang, Binsheng He, Jianjun He, Li Yan and Tianyuan Ci and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Xiaojun Liu

29 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojun Liu China 10 129 99 68 65 55 30 365
Zhe Liu China 11 154 1.2× 47 0.5× 34 0.5× 65 1.0× 84 1.5× 60 359
Yaowei Ai China 11 268 2.1× 116 1.2× 33 0.5× 171 2.6× 71 1.3× 18 572
Yukiko Nagashima Japan 12 94 0.7× 90 0.9× 16 0.2× 55 0.8× 84 1.5× 34 331
Xi Cheng China 12 168 1.3× 157 1.6× 78 1.1× 41 0.6× 105 1.9× 30 492
Haifeng Wang China 10 153 1.2× 53 0.5× 43 0.6× 98 1.5× 62 1.1× 43 357
Jibin Xu China 14 231 1.8× 57 0.6× 30 0.4× 59 0.9× 112 2.0× 32 439
Liangliang Sun China 9 148 1.1× 83 0.8× 46 0.7× 49 0.8× 54 1.0× 27 314

Countries citing papers authored by Xiaojun Liu

Since Specialization
Citations

This map shows the geographic impact of Xiaojun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Liu more than expected).

Fields of papers citing papers by Xiaojun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Liu. The network helps show where Xiaojun Liu may publish in the future.

Co-authorship network of co-authors of Xiaojun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojun Liu. A scholar is included among the top collaborators of Xiaojun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojun Liu. Xiaojun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Liu, Xiaojun, et al.. (2024). Product catalysis dual entropy-driven amplification reaction strategy for miRNA-21 detection in glioblastoma. Microchemical Journal. 206. 111515–111515. 1 indexed citations
4.
Chen, G., Hao Sun, Yunxia Chen, et al.. (2024). Perineural Invasion in Cervical Cancer: A Hidden Trail for Metastasis. Diagnostics. 14(14). 1517–1517. 2 indexed citations
5.
Zhang, Juan, Juan Zhang, Xiaojun Liu, et al.. (2024). Water involved in transformation of soil organo-mineral fractions during catalytic thermal desorption of dioxins-like polychlorinated biphenyls. Journal of Cleaner Production. 486. 144543–144543. 2 indexed citations
6.
7.
Zhang, Xiaoyan, Zhijian Huang, Xiaojun Liu, et al.. (2024). Macrophages Promote Subtype Conversion and Endocrine Resistance in Breast Cancer. Cancers. 16(3). 678–678. 1 indexed citations
8.
Mao, Zhimin, et al.. (2023). Ferroptosis contributes to cyclophosphamide-induced hemorrhagic cystitis. Chemico-Biological Interactions. 384. 110701–110701. 13 indexed citations
9.
Liu, Xiaojun, et al.. (2023). Integrated 16 S rRNA gene sequencing and serum metabolomics approaches to decipher the mechanism of Qingre Lidan decoction in the treatment of cholestatic liver injury. Journal of Pharmaceutical and Biomedical Analysis. 234. 115535–115535. 3 indexed citations
10.
Yu, Xinyuan, et al.. (2023). Jionoside A1 alleviates ischemic stroke ischemia/reperfusion injury by promoting Nix-mediated mitophagy. Cellular and Molecular Biology. 69(8). 237–245. 7 indexed citations
11.
Mu, Yuxin, Yanchun Meng, Yiqun Du, Xiaojun Liu, & Jian Zhang. (2023). Clinical characteristics and treatment outcomes of HER2 mutation and HER2 fusion in 22 patients with advanced breast cancer. Thoracic Cancer. 14(34). 3381–3388. 3 indexed citations
13.
Gong, Xiaodi & Xiaojun Liu. (2022). In-depth analysis of the expression and functions of signal transducers and activators of transcription in human ovarian cancer. Frontiers in Oncology. 12. 1054647–1054647. 4 indexed citations
14.
He, Binsheng, Jidong Lang, Bo Wang, et al.. (2020). TOOme: A Novel Computational Framework to Infer Cancer Tissue-of-Origin by Integrating Both Gene Mutation and Expression. Frontiers in Bioengineering and Biotechnology. 8. 394–394. 73 indexed citations
16.
Liu, Xiaojun, Lianxing Li, Lihong Peng, et al.. (2020). Predicting Cancer Tissue-of-Origin by a Machine Learning Method Using DNA Somatic Mutation Data. Frontiers in Genetics. 11. 674–674. 10 indexed citations
17.
Liu, Xiaojun, et al.. (2016). Mechanism-Based Drug Combinations with the DNA Strand–Breaking Nucleoside Analog CNDAC. Molecular Cancer Therapeutics. 15(10). 2302–2313. 4 indexed citations
18.
Yu, Lin, Kun Li, Xiaojun Liu, et al.. (2013). In Vitro and In Vivo Evaluation of a Once-weekly Formulation of an Antidiabetic Peptide Drug Exenatide in an Injectable Thermogel. Journal of Pharmaceutical Sciences. 102(11). 4140–4149. 40 indexed citations
19.
Wei, Guochao, Jing Chen, Aiyun Liu, et al.. (2012). Prevalence of Helicobacter pylori vacA, cagA and iceA genotypes and correlation with clinical outcome. Experimental and Therapeutic Medicine. 4(6). 1039–1044. 26 indexed citations
20.
Liu, Xiaojun, Christopher Bellamy, Matthew A. Bailey, et al.. (2009). Angiotensin-converting Enzyme Is a Modifier of Hypertensive End Organ Damage. Journal of Biological Chemistry. 284(23). 15564–15572. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026